Novel Orally Bioavailable Small Molecules with Lower Toxicity
Innovation through research and discovery
Services
Services Provided
Contract Research:
Testing of pharmaceutical drugs for lymphatic uptake.
- Sample collection and quantification of lymphatic fluid and plasma and provide pharmacokinetic analysis of drugs and test compounds using LC/MS.
- Longitudinal analysis of lymph node drug uptake by LC/MS.
- Determination of drug lymphatic/plasma ratio.
- Synthetic chemical design and modification of key compounds to aid in lymphatic absorption and expand pipeline and patent portfolio.
Announcements
Specialists in the collection and analysis of drugs for pharmaceutical and biotech companies from plasma and lymphatic systems through contracting services.
Partnerships Available
Available partnerships to jointly develop in-house proprietary series of therapeutic compounds which have been demonstrated to be lymphatically-absorbed following oral administration.
Unique Opportunities
Lympharma has unique capabilities for design of lymphatically-absorbed small molecules.
Site Content
News
Nature Communications 2022 publication describing a first-in-class "Lymphatropic" multi-targeted kinase inhibitor for myelofibrosis therapy. https://lnkd.in/g9U57MpH